Citations 0
May 14, 2003

Cost-effectiveness of Screening for Lung Cancer—Reply

Author Affiliations

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;289(18):2357. doi:10.1001/jama.289.18.2357-a

To the Editor: Dr Mahadevia and colleagues1 concluded that helical computed tomography (CT) should not be used as a screening tool for lung cancer. They based their conclusion on the results of their cost-effectiveness analysis, which relied on several assumptions about the costs and benefits of helical CT screening. I believe that these assumptions were overly optimistic, however, and that helical CT is thus probably even less effective than the authors conclude.

First Page Preview View Large
First page PDF preview
First page PDF preview